Abuse liability of intravenous buprenorp
β
Sandra D. Comer; Maria A. Sullivan; Suzanne K. Vosburg; Jeanne Manubay; Leslie A
π
Article
π
2010
π
John Wiley and Sons
π
English
β 328 KB
## ABSTRACT **Background** Sublingual buprenorphine is an effective maintenance treatment for opioid dependence, yet intravenous buprenorphine misuse occurs. A buprenorphine/naloxone formulation was developed to mitigate this misuse risk. This randomized, doubleβblind, crossβover study was conducte